Using transcutaneous carbon dioxide monitor (TOSCA 500) to detect respiratory failure in patients with amyotrophic lateral sclerosis: A validation study

Amyotrophic Lateral Sclerosis

Volumn 13, Issue 6, 2012, Pages 528-532

  Rafiq, Muhammad K ^a   Bradburn, Michael ^b   Proctor, Alison R ^a   Billings, Catherine ^c   Bianchi, Stephen ^c   McDermott, Christopher J ^a   Shaw, Pamela J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Neuromuscular respiratory failure; Partial transcutaneous pressure of carbon dioxide

Indexed keywords

CARBON DIOXIDE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD CARBON DIOXIDE TENSION; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MALE; MONITOR; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY FAILURE; TRANSCUTANEOUS CARBON DIOXIDE MONITORING; VALIDATION PROCESS; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD GAS MONITORING, TRANSCUTANEOUS; CARBON DIOXIDE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVATION; PARTIAL PRESSURE; RESPIRATORY INSUFFICIENCY;

EID: 84866068203     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2012.688836     Document Type: Article

References (11)

1. McDermott CJ, Shaw PJ. Diagnosis and management of motor neurone disease. Br Med J. 2008;336:658-62.
2. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: A randomized controlled trial. Lancet Neurology. 2006; 5:140-7.
3. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice para meter update. The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioural impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1227-33.
4. Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124:2000-13.
5. McVicar J, Eager R. Validation study of a transcutaneous carbon dioxide monitor in patients in the emergency department. Emergency Medicine Journal. 2009;26:344-6.
6. Storre JH, Steurer B, Kabitz HJ, Dreher M, Windisch W. Transcutaneous PCO 2 monitoring during initiation of noninvasive ventilation. Chest. 2007;132:1810-6.
7. Parker SM, Gibson GJ. Evaluation of a transcutaneous carbon dioxide monitor (' TOSCA ') in adult patients in routine respiratory practice. Respiratory Medicine. 2007;101: 261-4.
8. Wimpress S, Vara DD, Brightling CE. Improving the sampling technique of arterialized capillary samples to obtain more accurate PaO 2 measurements. Chronic Respiratory Disease. 2005;2:47-50.
9. Sauty A, Uldry C, Debetaz LF, Leuenberger P, Fitting JW. Differences in PO 2 and PCO 2 between arterial and arterialized earlobe samples. European Respiratory Journal. 1996;9: 186-9.
10. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-10.
11. Nicolini A, Ferrari MB. Evaluation of a transcutaneous carbon dioxide monitor in patients with acute respiratory failure. Annals of Thoracic Medicine. 2011;6:217-20